CM-4620 is a drug which acts as a selective inhibitor of the calcium channel ORAI1. It has antiinflammatory effects and is being researched for the treatment of pancreatitis.[1]
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C19H11ClF3N3O3 |
Molar mass | 421.76 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ Waldron RT, Chen Y, Pham H, Go A, Su HY, Hu C, et al. (June 2019). "The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis". The Journal of Physiology. 597 (12): 3085–3105. doi:10.1113/JP277856. PMC 6582954. PMID 31050811.